Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Acidosis and Tumor Progression

Cancer Pathophysiology

What is Immunochemotherapy?

Overview of Cell Viability and Cytotoxicity

Cutaneous Manifestations of Internal Malignancy

Metastatic Migration in Cancer may be Influenced by Metabolism

What Causes Cancer?

Hot vs Cold: the differences between tumor types

The Cancer Cell Surface Proteome as a Therapeutic Target

See more featured articles »

Myc Mutations and Cancer

Cancer Screening Considerations: Balancing the Benefits and Risks

Cancer Research

CDK9 and Cancer

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Using Biomarkers to Detect Cancer

Cancer Symptoms

Secondary Lung Cancer

The Biochemistry of Breast Cancer Screening

Targeted Cancer Therapies

Insight into Cancer Vaccines

Caring for a Loved One with Cancer

Living with Cancer Pain

Pediatric Cancer

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

The Effects of Cancer on Family Life

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Microfluidic cancer treatment screen combined with flow cytometry

What is Tumorigenesis?

Cancer History

Cancer Glossary

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Cancer Prognosis

Cancer Classification

Cancer Epidemiology

Insights into Oncofertility

Effects of Social and Economic Deprivation on Cancer Mortality

Why are Cancer Cell Lines Useful?

Cancer Prevention: Lowering your Risk

Transforming Cancer Care through Genomic Testing

Extracellular Vesicles as Floating Cancer Biomarkers

TARDIS: The Improved Method of Detecting Breast Cancer

Cancer Pain Management

British Pioneers in Cancer Biology

Is Cancer a Metabolic Disorder?

Assay for Monitoring and Treating Malignant Brain Tumors

Investigating the Molecular Mechanisms of Cancer

What is the Tumor Microenvironment?

What is Cancer?

Secondary Brain Cancer

What is Merkel Cell Carcinoma?

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Hypoxia Markers and Their Importance

Cancer Diagnosis

What Role do Biobanks Play in Cancer Research?

Exploiting Enzymes in Cancer Diagnosis and Therapy

Cancer Pain

Cancer Management

What is Cancer of Unknown Primary?

Latest Cancer News and Research

Nearly one third of patients with advanced melanoma saw tumors disappear completely after receiving TIL therapy plus pembrolizumab immunotherapy

Results from a clinical trial have revealed nearly one third (29.2 percent) of patients with advanced melanoma saw their tumors disappear completely on scans after receiving lifileucel TIL therapy alongside an immune checkpoint inhibitor, pembrolizumab, as a first-line treatment.

24 Oct 2026

Six-gene score could improve survival predictions for acute myeloid leukemia

The activity of six different genes can help determine patient survival of acute myeloid leukemia (AML), according to a study published today in Science Advances.

23 Oct 2026

Study reveals how cancer cells survive chemotherapy in a zombie-like state

Scientists at Trinity College Dublin have made an important breakthrough in understanding how cancer cells can evade the cell-killing effects of chemotherapy and enter a "zombie-like state", called premature senescence, that can attract the wound healing properties of the immune system.

23 Oct 2026

Common kidney tests underestimate chronic kidney disease in cancer patients

New research indicates that commonly used measures of kidney function largely underestimate the prevalence of chronic kidney disease (CKD) in patients with cancer. The findings will be presented at ASN Kidney Week 2026 October 22–25.

23 Oct 2026

KRAS-targeting vaccine prompts immune responses in pancreatic cancer patients

An investigational vaccine helped the immune system recognize and respond to mutations that drive most pancreatic cancers, according to results from a randomized phase 2 clinical trial led by Mayo Clinic researchers.

23 Oct 2026

Digital tools and phone coaching boost cancer genetic testing uptake

About 10% of cancers are linked to an inherited genetic variant, but as few as 1 in 15 cancer patients eligible for genetic testing complete it.

23 Oct 2026

Targeted drug extends survival across diverse pancreatic cancer patient groups

A new analysis of a phase 3 clinical trial found that the targeted drug daraxonrasib improved survival compared with standard chemotherapy across multiple groups of patients with advanced pancreatic cancer, including those with different RAS mutations and those without an identified RAS mutation.

23 Oct 2026

PARP1 remodels nucleosomes to help cells repair damaged DNA

When DNA is damaged, cellular processes respond and repair the DNA. Inhibiting DNA damage repair can be therapeutically beneficial in cancers with genetic vulnerabilities related to DNA damage response.

23 Oct 2026

Researchers call for microbiome moonshot to tackle chronic diseases

Rutgers researchers are part of an international call for a microbiome moonshot, a massive, coordinated effort to pinpoint how certain microorganisms inside us drive chronic disease and how others can be harnessed for repair.

23 Oct 2026

Researchers identify molecular target to improve pancreatic cancer treatment

Pancreatic cancer is one of the most aggressive and difficult-to-treat cancers. One reason for its resistance to therapy is the dense tissue surrounding the tumor, which acts as a protective barrier and suppresses the immune response.

23 Oct 2026

New playground design aims to protect children from harmful UV rays

A new design methodology for school playgrounds is demonstrating how children can still enjoy their play time whilst being protected from the harmful effects of the sun.

23 Oct 2026

Study identifies potential new ways to treat the most common type of bowel cancer

Major new research published today identifies potential new ways to treat the most common type of bowel cancer in Ireland.

23 Oct 2026

Decipher tissue-based molecular test helps personalize high-risk prostate cancer treatment

Prostate cancer is the most common cancer in men – in 2013, it affected more than one million men across the world.

23 Oct 2026

Medicare is more broken than we thought

By Oct. 1, at least 2 million seniors will have received alarming notices: Their health plans — which they get through Medicare Advantage, the version of Medicare run by private health insurance companies — will disappear at the end of the year.

23 Oct 2026

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Discover how omics is transforming life sciences with expert insights from Dr. Shi-Qi An on multiomics, single-cell research and drug discovery.

23 Oct 2026

Researchers harness cancer cells' carbon monoxide to produce anticancer drug

What if we could use a cancer's own byproduct to make drugs that destroy tumor cells from the inside? That is exactly what Katsunori Tanaka and his team have done at the RIKEN Pioneering Research Institute (PRI) in Japan.

23 Oct 2026

Dual-targeted therapy shows promise against metastatic triple-negative breast cancer

A new preclinical study suggests that attacking triple-negative breast cancer (TNBC) in two ways at once can kill cancer cells, slow tumor growth and limit the cancer's spread. Researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) developed the approach.

23 Oct 2026

AI scoring tool may guide skin biopsy decision

Mayo Clinic researchers have found that an artificial intelligence (AI) tool may provide dermatologists with additional information to help assess whether skin lesions are cancerous and inform their clinical decisions about whether to biopsy or monitor them, according to a study published in Mayo Clinic Proceedings.

22 Oct 2026

Scientists studied one million immune cells and found clues to future disease risk

Researchers developed a single-cell atlas of one million human neutrophils, identifying distinct immune cell populations and gene-expression patterns across tissues, infections, cancer, and other health conditions. Certain neutrophil signatures were associated with metabolic dysfunction, cancer outcomes, and mortality, while higher routine neutrophil counts, even within the normal range, were linked to an increased risk of chronic disease.

22 Oct 2026

Unstable immune cells linked to severe cancer immunotherapy side effects

Scientists at the University of Pittsburgh uncovered the unstable immune cells that can cause up to 40% of immunotherapy patients to experience serious side effects and showed that diet and microbiome composition influence the side effect's severity.

22 Oct 2026